-
Bharti Airtel
1,956.00 2,174.70(%) -
Bluestone Jewel
872.60 872.60(%) -
Anthem Bioscienc
735.10 579.45(%) -
IndusInd Bank
1,077.80 1,077.80(%) -
M & M Fin. Serv.
384.55 412.30(%) -
Data Pattern
4,800.00 4,955.00(%) -
TVS Motor Co.
3,965.00 3,970.00(%) -
Cummins India
5,635.00 6,142.80(%) -
Bajaj Auto
11,025.00 11,025.00(%) -
SBI Funds Mgt.
582.55 582.55(%) -
Bandhan Bank
169.65 134.30(%) -
HDFC Bank
750.25 726.75(%) -
Kalyan Jewellers
601.25 617.30(%) -
Eternal
275.70 212.55(%) -
Reliance Industries
1,284.00 1,253.65(%) -
Bajaj Finance
1,056.30 788.40(%) -
Dixon Technolog.
13,650.00 9,605.05(%) -
Himadri Special
760.20 420.00(%) -
Titan Company
4,730.10 4,730.10(%) -
Nestle India
1,509.75 1,509.75(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Aarti Pharmalabs Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
- Aarti Group
- BSE Code : 75909.0
- ISIN : INE0LRU01027
-
Today’s Low
670.05 -
Today’s High
700.30
-
Open
700.00 -
Perv Close
702.35 -
52W Low
585.00 -
52W High
969.50
Key Indicators
-
P/E(TTM)
34.25
-
Mar.Cap (₹Cr.)
6,100.03
-
Div & Yield %
0.52
-
Book Value(₹)
218.61
-
Debt-Equity Ratio
-4.22
-
AGM Date
22-Jul-2026
-
EPS
19.66
-
P/E Ratio
34.25
Financials Ratios
-
Debt-Equity Ratio
0.15
-
Mar.Cap (₹Cr.)
6,100.03
-
RONW (%)
13.08
-
ROCE (%)
16.60
Score Board
-
Equity (₹ in Cr.)
45.34
-
BV (₹)
218.60
-
Sales( ₹ in Cr.)
1,797.55
-
NP (in Cr.)
178.30
-
NP Var(%)
-31.0
-
Div%
70.0
-
CPS (₹)
31.20
-
EPS (₹)
19.70
-
Traded Value (₹ in Lakhs)
6,105.93
-
52 Week High
969.50
-
52 Week Low
585.00
-
Price BSE
673.0
-
Price NSE
673.00
-
Market Capital( in Cr.)
6,105.93
-
P/C Ratio
21.60
-
P/E Ratio
34.20
-
Price Vs.BV
19.70
-
25-Jun-2026( 01:30)
Corporate News - Aarti... - Aarti Pharmalabs has allotted...
-
26-May-2026( 10:53)
Corporate News - Board... - Aarti Pharmalabs announced th...
-
26-May-2026( 07:38)
Results - Announcements - Aarti... - Net profit of Aarti Pharmalabs...
-
18-May-2026( 12:14)
Corporate News - Aarti... - Aarti Pharmalabs has revised...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 1,771.35 | 1,502.13 | 1,511.25 | 941.02 | 0.00 | 0.00 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1,771.35 | 1,502.13 | 1,511.25 | 941.02 | 0.00 | 0.00 |
| Other Income | 14.49 | 11.01 | 1.28 | 2.51 | 0.00 | 0.00 |
| Stock Adjustments | -47.85 | 23.36 | 91.22 | 32.54 | 0.00 | 0.00 |
| Total Income | 1,737.99 | 1,536.50 | 1,603.75 | 976.07 | 0.00 | 0.00 |
| EXPENDITURE : | ||||||
| Raw Materials | 831.41 | 775.33 | 909.15 | 484.20 | 0.00 | 0.00 |
| Power and Fuel Cost | 80.19 | 82.92 | 74.22 | 43.43 | 0.00 | 0.00 |
| Employee Cost | 139.82 | 120.15 | 113.92 | 79.98 | 0.00 | 0.00 |
| Other Manufacturing Expenses | 118.83 | 109.26 | 91.11 | 164.69 | 0.00 | 0.00 |
| Selling and Administration Expenses | 101.22 | 66.55 | 82.93 | 21.46 | 0.00 | 0.02 |
| Miscellaneous Expenses | 25.49 | 25.13 | 22.80 | 0.01 | 0.00 | 0.00 |
| Employee Benefit Expenses | 139.82 | 120.15 | 113.92 | 79.98 | 0.00 | 0.00 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 1,296.95 | 1,179.33 | 1,294.14 | 793.78 | 0.00 | 0.02 |
| Operating Profit | 441.03 | 357.16 | 309.62 | 182.30 | 0.00 | -0.02 |
| Interest | 25.63 | 16.63 | 20.49 | 11.34 | 0.00 | 0.00 |
| Gross Profit | 415.40 | 340.53 | 289.13 | 170.96 | 0.00 | -0.02 |
| Depreciation | 79.06 | 66.01 | 55.77 | 37.23 | 0.00 | 0.00 |
| Profit Before Tax | 336.34 | 274.52 | 233.36 | 133.73 | 0.00 | -0.02 |
| Current Tax | 56.71 | 46.06 | 52.13 | 22.50 | 0.00 | 0.00 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 22.28 | 27.82 | 9.50 | 4.50 | 0.00 | 0.00 |
| Reported Net Profit | 257.35 | 200.65 | 171.73 | 106.73 | 0.00 | -0.02 |
| Extraordinary Items | 0.00 | 0.00 | 0.00 | 0.03 | 0.00 | 0.00 |
| Adjusted Net Profit | 257.35 | 200.65 | 171.73 | 106.70 | 0.00 | -0.02 |
| Adjustment below Net Profit | -1.42 | 0.00 | 0.00 | 599.24 | 0.00 | 0.00 |
| P & L Balance brought forward | 1,042.07 | 859.55 | 705.95 | -0.02 | -0.02 | 0.00 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 31.72 | 18.13 | 18.13 | 0.00 | 0.00 | 0.00 |
| P & L Balance carried down | 1,266.28 | 1,042.07 | 859.55 | 705.95 | -0.02 | -0.02 |
| Dividend | 0.00 | 0.00 | 18.13 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 100.00 | 60.00 | 40.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 5.00 | 3.00 | 2.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | 28.39 | 22.14 | 18.95 | 4,269.05 | -0.18 | -0.75 |
| Earnings Per Share(Adj)-Unit Curr | 28.39 | 22.14 | 18.95 | - | - | - |
| Book Value | 203.44 | 178.92 | 158.74 | 49,558.52 | 9.07 | 9.25 |
| Book Value(Adj)-Unit Curr | 203.44 | 178.92 | 158.74 | - | - | - |
